These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 29973656

  • 1. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
    Tian C, Wu H, Li C, Tian X, Sun Y, Liu E, Liao X, Song W.
    Gene Ther; 2018 Jul; 25(4):312-319. PubMed ID: 29973656
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
    Zheng WW, Zhou J, Zhang CH, Liu XS.
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
    Huang X, Qin J, Lu S.
    Int J Clin Exp Pathol; 2015 Jun; 8(2):1515-24. PubMed ID: 25973036
    [Abstract] [Full Text] [Related]

  • 4. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
    Sun M, Wang X, Tu C, Wang S, Qu J, Xiao S.
    Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
    [Abstract] [Full Text] [Related]

  • 5. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
    Chai N, Xie HH, Yin JP, Sa KD, Guo Y, Wang M, Liu J, Zhang XF, Zhang X, Yin H, Nie YZ, Wu KC, Yang AG, Zhang R.
    Biochem Biophys Res Commun; 2018 Jun 12; 500(4):924-929. PubMed ID: 29705704
    [Abstract] [Full Text] [Related]

  • 6. miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA.
    Cui W, Li Y, Xu K, Chen G, Lu X, Duan Q, Kang Z.
    Biochem Biophys Res Commun; 2016 Oct 28; 479(4):901-906. PubMed ID: 27641667
    [Abstract] [Full Text] [Related]

  • 7. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
    Hu G, Yan Z, Zhang C, Cheng M, Yan Y, Wang Y, Deng L, Lu Q, Luo S.
    J Exp Clin Cancer Res; 2019 May 09; 38(1):188. PubMed ID: 31072351
    [Abstract] [Full Text] [Related]

  • 8. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
    Zhang B, Zhang Y, Zou X, Chan AW, Zhang R, Lee TK, Liu H, Lau EY, Ho NP, Lai PB, Cheung YS, To KF, Wong HK, Choy KW, Keng VW, Chow LM, Chan KK, Cheng AS, Ko BC.
    J Pathol; 2017 Dec 09; 243(4):418-430. PubMed ID: 28862757
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
    Wei Y, Wang Z, Zong Y, Deng D, Chen P, Lu J.
    Biomed Pharmacother; 2020 May 09; 125():109890. PubMed ID: 32106369
    [Abstract] [Full Text] [Related]

  • 12. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
    Li H, Sun Q, Han B, Yu X, Hu B, Hu S.
    Int J Clin Exp Pathol; 2015 May 09; 8(5):4782-90. PubMed ID: 26191168
    [Abstract] [Full Text] [Related]

  • 13. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
    Zhang Y, Zheng D, Xiong Y, Xue C, Chen G, Yan B, Ye Q.
    FEBS Lett; 2014 May 21; 588(10):1913-20. PubMed ID: 24704686
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y, Zheng X.
    Oncol Rep; 2012 Aug 21; 28(2):701-6. PubMed ID: 22664953
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
    Jia P, Wei G, Zhou C, Gao Q, Wu Y, Sun X, Li X.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533034618765221. PubMed ID: 29618288
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W, Zou B, Liu L, Cui K, Gao J, Yuan S, Cong N.
    Oncotarget; 2016 Nov 08; 7(45):74059-74073. PubMed ID: 27677076
    [Abstract] [Full Text] [Related]

  • 17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 18. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
    Yu CP, Yu S, Shi L, Wang S, Li ZX, Wang YH, Sun CJ, Liang J.
    Mol Med Rep; 2017 Oct 07; 16(4):5181-5188. PubMed ID: 28849004
    [Abstract] [Full Text] [Related]

  • 19. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
    Yu M, Tang Z, Meng F, Tai M, Zhang J, Wang R, Liu C, Wu Q.
    Tumour Biol; 2016 Jan 07; 37(1):1289-97. PubMed ID: 26289845
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X, Xie T, Mao X, Xue L, Chu X, Chen L.
    Cell Physiol Biochem; 2016 Jan 07; 39(2):617-29. PubMed ID: 27415661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.